Abiopharma

🔍 Oswald Stephen G (Executive)

Company: DUCOMMUN INC /DE/ (DCO)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Sold 2,546 shares of Common Stock at $137.23 per share (Direct)
  Date: 2026-05-08 | Code: F | equity_swap_involved: false | shares_owned_after: 416,838.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,589 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: D | equity_swap_involved: false | shares_owned_after: 414,249.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Represents a reduction in shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement, on May 8, 2026, of 5,135 restricted stock units.
• F2: In connection with the operation of the Issuer's Second Amended and Restated Clawback Policy (the "Clawback Policy") with respect to the restatement and revision of the Issuer's previously issued financial statements, as reported in the Issuer's Form 8-K filed on May 1, 2026, the Issuer determined that the Reporting Person would not have earned certain compensation had such compensation been determined based on the restated financial statements. As a result, 5,135 stock units that vested on May 8, 2026 were not delivered to the Reporting Person and 2,589 shares of the Issuer's common stock were returned to the Issuer in accordance with the Issuer's Clawback Policy.